Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.08
+0.12 (1.34%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Nuvectis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 241 | 193 | 105 | 145 | 110 | - | |
| Market Cap Growth | 20.23% | 85.02% | -27.66% | 31.58% | - | - | |
| Enterprise Value | 209 | 158 | 87 | 122 | 86 | - | |
| Last Close Price | 9.08 | 7.55 | 5.41 | 8.34 | 7.50 | - | |
| PB Ratio | 12.66 | 10.50 | 10.76 | 11.84 | 7.72 | - | |
| P/TBV Ratio | 13.06 | 10.50 | 10.76 | 11.84 | 7.72 | - | |
| Net Debt / Equity Ratio | -1.72 | -1.72 | -1.91 | -1.57 | -1.41 | -1.35 | |
| Quick Ratio | 2.38 | 2.38 | 2.08 | 2.74 | 3.23 | 2.37 | |
| Current Ratio | 2.38 | 2.38 | 2.09 | 2.75 | 3.30 | 2.41 | |
| Return on Equity (ROE) | -188.03% | -188.03% | -173.41% | -168.51% | -206.81% | -609.74% | |
| Return on Assets (ROA) | -68.50% | -68.50% | -65.64% | -69.14% | -83.30% | - | |
| Return on Capital Employed (ROCE) | -149.80% | -149.80% | -204.30% | -179.50% | -126.80% | -136.70% | |
| Earnings Yield | -12.00% | -13.67% | -18.18% | -15.40% | -17.38% | - | |
| Buyback Yield / Dilution | -27.46% | -27.46% | -10.01% | -22.90% | -196.55% | -9.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.